US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alexander's

205.50

-1.5100-0.73%

Pre-market: 205.500.00000.00%05:24 EDT

Volume:12.28K

Turnover:2.52M

Market Cap:1.05B

PE:24.29

High:206.00

Open:205.36

Low:203.40

Close:207.01

Loading ...

Overview Company News Filings

ALX Oncology price target lowered to $1.20 from $2.20 at UBS

LifeSci Capital Reaffirms Their Hold Rating on ALX Oncology Holdings (ALXO)

ALX Oncology Phase 1/2 Evorpacept Trial to Treat B-cell Non-Hodgkin Lymphoma Shows Anti-tumor Activity

MT Newswires Live

ALX Oncology reports ‘encouraging’ final results from Phase 1 evorpacept trial

ALX Oncology Announces Encouraging Final Results from Phase 1 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with B-cell Non-Hodgkin Lymphoma

ALX Oncology's Phase 2 Trials of Evorpacept, Keytruda Combination in Head, Neck Cancers Fail to Meet Primary Endpoints

MT Newswires Live

ALX Oncology Reports ASPEN-03 and ASPEN-04 Phase 2 Trials Evaluating Evorpacept with a Checkpoint Inhibitor for the Treatment of Head and Neck Cancers Did Not Meet Primary Endpoints

Alexander's (ALX) Surges 4.0%: Is This an Indication of Further Gains?

New Strong Buy Stocks for April 10th

ALX Oncology receives IND clearance from FDA for ALX2004

ALX Oncology Receives IND Clearance from U.S. FDA for ALX2004, a Novel EGFR-targeted Antibody-drug Conjugate

Nyse Order Imbalance 1687.0 Shares on Buy Side

THOMSON REUTERS

New Strong Buy Stocks for April 3rd

Is Alexander's (ALX) Stock Outpacing Its Finance Peers This Year?

Alexander's (ALX) Upgraded to Strong Buy: Here's Why

Best Income Stocks to Buy for March 28th

Best Income Stocks to Buy for March 25th

Is Alexander's (ALX) Outperforming Other Finance Stocks This Year?

With 73% institutional ownership, Atlas Arteria Limited (ASX:ALX) is a favorite amongst the big guns

Simply Wall St.

Atlas Arteria's (ASX:ALX) Solid Earnings May Rest On Weak Foundations

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ALX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALX\",,,,,undefined,":{"symbol":"ALX","market":"US","secType":"STK","nameCN":"Alexander's","latestPrice":205.5,"timestamp":1745956800000,"preClose":207.01,"halted":0,"volume":12276,"hourTrading":{"tag":"盘前","latestPrice":205.5,"preClose":205.5,"latestTime":"05:24 EDT","volume":4,"amount":822,"timestamp":1746005046797},"delay":0,"floatShares":2125671,"shares":5107290,"eps":8.459999,"marketStatus":"Pre-Mkt","change":-1.51,"latestTime":"04-30 08:00:10 EDT","open":205.36,"high":206,"low":203.4,"amount":2518876.7331,"amplitude":0.01256,"askPrice":216,"askSize":150,"bidPrice":185,"bidSize":25,"shortable":3,"etf":0,"ttmEps":8.459999,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1746019800000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":-7416000000,"exchange":"NYSE","adjPreClose":205.5,"dividendRate":0.087591,"preHourTrading":{"tag":"盘前","latestPrice":205.5,"preClose":205.5,"latestTime":"05:24 EDT","volume":4,"amount":822,"timestamp":1746005046797},"postHourTrading":{"tag":"盘后","latestPrice":205.5,"preClose":205.5,"latestTime":"16:05 EDT","volume":298,"amount":61239,"timestamp":1745957112622},"volumeRatio":1.578622513052772},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALX\",,,,,undefined,":{"symbol":"ALX","floatShares":2125671,"roa":"3.73%","roe":"20.96%","lyrEps":8.464626,"volumeRatio":1.578622513052772,"shares":5107290,"dividePrice":18,"high":206,"amplitude":0.01256,"preClose":207.01,"low":203.4,"week52Low":184.76,"pbRate":"5.93","psRate":"4.64","week52High":251.63,"institutionHeld":0.3404,"latestPrice":205.5,"committee":-0.714286,"eps":8.459999,"divideRate":0.087591,"volume":12276,"delay":0,"ttmEps":8.459999,"open":205.36,"prevYearClose":200.06,"prevWeekClose":200.61,"prevMonthClose":209.16,"prevQuarterClose":209.16,"fiveDayClose":202.82,"twentyDayClose":209.16,"sixtyDayClose":189.95,"earningDate":1746374400000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2530805292","title":"ALX Oncology price target lowered to $1.20 from $2.20 at UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2530805292","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530805292?lang=en_us&edition=fundamental","pubTime":"2025-04-28 22:30","pubTimestamp":1745850634,"startTime":"0","endTime":"0","summary":"UBS lowered the firm’s price target on ALX Oncology (ALXO) to $1.20 from $2.20 and keeps a Buy rating on the shares. ALX Oncology’s ASPEN-03/04 tri...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alx-oncology-price-target-lowered-to-1-20-from-2-20-at-ubs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alx-oncology-price-target-lowered-to-1-20-from-2-20-at-ubs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALX"],"gpt_icon":0},{"id":"2530034285","title":"LifeSci Capital Reaffirms Their Hold Rating on ALX Oncology Holdings (ALXO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2530034285","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530034285?lang=en_us&edition=fundamental","pubTime":"2025-04-28 21:35","pubTimestamp":1745847355,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Sam Slutsky maintained a Hold rating on ALX Oncology Holdings (ALXO – Research Report) today. The company’s shares opened t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lifesci-capital-reaffirms-their-hold-rating-on-alx-oncology-holdings-alxo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lifesci-capital-reaffirms-their-hold-rating-on-alx-oncology-holdings-alxo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALXO","ALX"],"gpt_icon":0},{"id":"2530163491","title":"ALX Oncology Phase 1/2 Evorpacept Trial to Treat B-cell Non-Hodgkin Lymphoma Shows Anti-tumor Activity","url":"https://stock-news.laohu8.com/highlight/detail?id=2530163491","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530163491?lang=en_us&edition=fundamental","pubTime":"2025-04-26 01:44","pubTimestamp":1745603098,"startTime":"0","endTime":"0","summary":"ALX Oncology  said Friday that data from its ongoing phase 1/2 trial of its evorpacept investigational drug in combination with rituximab and lenalidomide in patients with indolent and aggressive relapsed or refractory B-cell non-Hodgkin lymphoma showed anti-tumor activity.A median follow-up of 28 months on the patients revealed that the two-year progression-free survival rate was 69% and the two-year overall survival rate was 84%, while 80% achieved complete responses, the company said.The complete response rate was higher than that of patients who received the standard-of-care rituximab and lenalidomide treatment, the company said.The phase 2 portion of the study in patients with previously untreated indolent non-Hodgkin lymphoma is ongoing and has completed enrollment, the company added.Shares of the company were down 9.3% in recent Friday trading.Price: 0.55, Change: -0.06, Percent Change: -9.32","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4080","BK4231","ALXO","ALX","BK4139"],"gpt_icon":0},{"id":"2530150074","title":"ALX Oncology reports ‘encouraging’ final results from Phase 1 evorpacept trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2530150074","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530150074?lang=en_us&edition=fundamental","pubTime":"2025-04-26 01:15","pubTimestamp":1745601358,"startTime":"0","endTime":"0","summary":"ALX Oncology (ALXO) announced “encouraging” data from an ongoing Phase 1/2 investigator-sponsored trial of the company’s lead clinical candidate, e...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alx-oncology-reports-encouraging-final-results-from-phase-1-evorpacept-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alx-oncology-reports-encouraging-final-results-from-phase-1-evorpacept-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4080","ALX","BK4139","BK4231","ALXO"],"gpt_icon":0},{"id":"2530685901","title":"ALX Oncology Announces Encouraging Final Results from Phase 1 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with B-cell Non-Hodgkin Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2530685901","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530685901?lang=en_us&edition=fundamental","pubTime":"2025-04-26 01:10","pubTimestamp":1745601000,"startTime":"0","endTime":"0","summary":"- Data to be presented at AACR 2025 Annual Meeting suggest the combination of ALX Oncology’s investigational CD47-blocker, evorpacept, plus rituximab and lenalidomide  was well-tolerated and demonstrated promising anti-tumor activity. - Combination generated complete responses  in 83% of patients with indolent relapsed or refractory B-cell non-Hodgkin lymphoma  comparing favorably to 34% historical CR rate with R2 alone. - Phase 2 portion of trial in patients with previously untreated indolent NHL  is ongoing and has completed enrollment. After a median follow-up of 28 months  the two-year progression-free survival  rate was 69% and two-year overall survival  rate was 84%. Sixteen patients (80%) achieved complete responses and the best overall response rate  was 90%. As previously repo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/alx-oncology-announces-encouraging-final-171000715.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4211","BK4231","ORR","BK4080","ALX","CR","BK4139","BK4195","BK4161","OS","SMP","BK4097","ALXO","PFS","BK4124"],"gpt_icon":0},{"id":"2530131735","title":"ALX Oncology's Phase 2 Trials of Evorpacept, Keytruda Combination in Head, Neck Cancers Fail to Meet Primary Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2530131735","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530131735?lang=en_us&edition=fundamental","pubTime":"2025-04-25 21:52","pubTimestamp":1745589120,"startTime":"0","endTime":"0","summary":"ALX Oncology  said Friday that two phase 2 trials evaluating evorpacept in combination with Merck's  Keytruda in patients with advanced head and neck squamous cell carcinoma failed to meet their primary endpoints of improved objective response rates.The company said efficacy data from the trials do not support advancing the combination into a registrational study and it will no longer pursue the combination therapy in advanced head and neck squamous cell carcinoma.ALX said, however, that several trials of evorpacept in combination with other anti-cancer antibodies will continue based on established proof-of-concept.ALX Oncology shares were down more than 4% in recent Friday trading.Price: 0.58, Change: -0.02, Percent Change: -3.49","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0266013472.USD","LU1291159041.SGD","LU0070302665.USD","BK4516","SG9999015341.SGD","LU1989771016.USD","LU0965508806.USD","LU0058720904.USD","BK4139","LU1023059063.AUD","LU1093756325.SGD","LU1061106388.HKD","IE00B1BXHZ80.USD","LU0965509101.SGD","LU0289739699.SGD","LU1941712348.USD","MRK","LU1069347547.HKD","IE00BJJMRZ35.SGD","LU1093756168.USD","ALX","LU2468319806.SGD","LU1941712264.USD","LU1116320737.USD","LU2023250504.SGD","SG9999014559.SGD","LU2023250843.SGD","BK4585","LU2324357040.USD","LU1037948541.HKD","LU0006306889.USD","SGXZ57979304.SGD","IE0009355771.USD","SG9999001176.SGD","LU2089984988.USD","LU1430594728.SGD","IE00BLSP4239.USD","LU1066053197.SGD","IE0002141913.USD","LU2112291526.USD","ALXO","LU0965509010.AUD","LU0985320562.USD","LU1585245621.USD","LU0965509283.SGD","LU1066051225.USD","BK4231","BK4533","LU0203347892.USD","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"2530513653","title":"ALX Oncology Reports ASPEN-03 and ASPEN-04 Phase 2 Trials Evaluating Evorpacept with a Checkpoint Inhibitor for the Treatment of Head and Neck Cancers Did Not Meet Primary Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2530513653","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530513653?lang=en_us&edition=fundamental","pubTime":"2025-04-25 21:00","pubTimestamp":1745586000,"startTime":"0","endTime":"0","summary":"In ASPEN-03 and ASPEN-04 trials, efficacy data do not support advancing evorpacept in combination with Merck’s anti-PD-1 therapy, KEYTRUDA , into a registrational study. Company remains confident in continuing to pursue evorpacept in multiple clinical trials, based on the different mechanism of evorpacept in combination with anti-cancer antibodies, as evidenced by durable clinical response and consistent safety data in prior clinical trials. In the ASPEN-03 and ASPEN-04 clinical trials, evorpacept was combined with pembrolizumab with or without chemotherapy to investigate a second and distinct mechanism of action. This discrete approach explored the concept that evorpacept may enhance T-cell priming by activating dendritic cells and stimulating the adaptive immune system. The trial outcomes were not sufficiently supportive of advancing evorpacept in combination with pe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/alx-oncology-reports-aspen-03-130000813.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ALX","LU1037948897.HKD","LU1037948541.HKD","LU0265550946.USD","LU0965508806.USD","LU0234572021.USD","LU1116320901.HKD","LU1116320737.USD","LU1069347547.HKD","IE00B2B36J28.USD","ORR","IE00BN8TJ469.HKD","LU1035773651.USD","ALXO","LU2461242641.AUD","BK4516","LU1066051811.HKD","LU1934455194.USD","LU2468319806.SGD","SG9999014559.SGD","LU1989772840.SGD","LU2089984988.USD","LU1917777945.USD","IE000M9KFDE8.USD","BK4097","BK4080","IE0002141913.USD","LU0965509283.SGD","IE00BFTCPJ56.SGD","BK4231","SG9999014542.SGD","MRK","LU2106854487.HKD","LU1057294990.SGD","LU1934455277.USD","SG9999014567.USD","BK4550","LU1974910355.USD","LU1983299246.USD","LU1291159041.SGD","OS","PFS","LU0211331839.USD","LU1093756325.SGD","IE00B1BXHZ80.USD","SG9999001176.USD","LU1941712264.USD","LU0861579265.USD","LU0203345920.USD","LU1934455863.HKD"],"gpt_icon":0},{"id":"2526592784","title":"Alexander's (ALX) Surges 4.0%: Is This an Indication of Further Gains?","url":"https://stock-news.laohu8.com/highlight/detail?id=2526592784","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526592784?lang=en_us&edition=fundamental","pubTime":"2025-04-10 21:47","pubTimestamp":1744292820,"startTime":"0","endTime":"0","summary":"Alexander's ALX shares ended the last trading session 4% higher at $201.29. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 10.4% loss over the past four weeks.The increased investor optimism in the stock can be attributed to President Donald Trump’s recent announcement to put a 90-day pause on the reciprocal tariff for most countries.This real estate investment trust is expected to post quarterly funds from operation  of $3.57 per share in its upcoming report, which represents a year-over-year change of -28.3%. Revenues are expected to be $56 million, down 8.8% from the year-ago quarter.While FFO and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in FFO estimate revisions and near-term stock price movements.Alexander's belongs to the Zacks REIT and Equity Trust - Other industry. Another st","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/alexanders-alx-surges-4-0-134700567.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4203","ALX","BK4588","BK4080","BK4231","OHI","BK4585","BK4225"],"gpt_icon":0},{"id":"2526856261","title":"New Strong Buy Stocks for April 10th","url":"https://stock-news.laohu8.com/highlight/detail?id=2526856261","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526856261?lang=en_us&edition=fundamental","pubTime":"2025-04-10 19:16","pubTimestamp":1744283760,"startTime":"0","endTime":"0","summary":"Here are five stocks added to the Zacks Rank #1  List today:. Alexander's, Inc.ALX: This real estate investment trust has seen the Zacks Consensus Estimate for its current year earnings increasing 15% over the last 60 days.Molson Coors Beverage CompanyTAP: This beverage company has seen the Zacks Consensus Estimate for its current year earnings increasing 7.2% over the last 60 days.Molson Coors Beverage Company price-consensus-chart | Molson Coors Beverage Company Quote. Telefónica, S.A.TEF: This telecommunications services provider has seen the Zacks Consensus Estimate for its current year earnings increasing 6.5% over the last 60 days.Chain Bridge Bancorp, Inc.CBNA: This bank holding company has seen the Zacks Consensus Estimate for its current year earnings increasing 10.4% over the last 60 days.Chain Bridge Bancorp, Inc. price-consensus-chart | Chain Bridge Bancorp, Inc. Quote. Sprouts Farmers Market, Inc.SFM: This natural and organic food retailer has seen the Zacks Consensus Esti","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/strong-buy-stocks-april-10th-111600293.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0321505439.SGD","LU0053671581.USD","TEF","CBNA","BK4231","LU2355687059.USD","TAP","BK4115","LU0985481810.HKD","BK4211","LU0321505868.SGD","BK4588","LU0306807586.USD","BK4585","BK4113","BK4158","SFM","ALX","IE00B3T34201.USD","LU0225284248.USD","BK4532","LU0225771236.USD","LU0306806265.USD","BK4080"],"gpt_icon":0},{"id":"2525048947","title":"ALX Oncology receives IND clearance from FDA for ALX2004","url":"https://stock-news.laohu8.com/highlight/detail?id=2525048947","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525048947?lang=en_us&edition=fundamental","pubTime":"2025-04-07 20:30","pubTimestamp":1744029040,"startTime":"0","endTime":"0","summary":"ALX Oncology (ALXO) announced receipt of U.S. Food and Drug Administration clearance for the Investigational New Drug application for ALX2004, the ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alx-oncology-receives-ind-clearance-from-fda-for-alx2004?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alx-oncology-receives-ind-clearance-from-fda-for-alx2004?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4231","ALX","BK4080","BK4139","ALXO"],"gpt_icon":0},{"id":"2525017552","title":"ALX Oncology Receives IND Clearance from U.S. FDA for ALX2004,  a Novel EGFR-targeted Antibody-drug Conjugate","url":"https://stock-news.laohu8.com/highlight/detail?id=2525017552","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525017552?lang=en_us&edition=fundamental","pubTime":"2025-04-07 20:00","pubTimestamp":1744027200,"startTime":"0","endTime":"0","summary":"ALX2004 is a potential best- and first-in-class antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid tumors that was created from ALX Oncology’s proprietary linker-payload platform","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/07/3056683/0/en/ALX-Oncology-Receives-IND-Clearance-from-U-S-FDA-for-ALX2004-a-Novel-EGFR-targeted-Antibody-drug-Conjugate.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4080","BK4231","ALX","ADC"],"gpt_icon":0},{"id":"2524188762","title":"Nyse Order Imbalance  1687.0 Shares on Buy Side","url":"https://stock-news.laohu8.com/highlight/detail?id=2524188762","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524188762?lang=en_us&edition=fundamental","pubTime":"2025-04-04 03:50","pubTimestamp":1743709807,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250403:nAQN2K8PGI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4080","BK4231","ALX"],"gpt_icon":0},{"id":"2524253229","title":"New Strong Buy Stocks for April 3rd","url":"https://stock-news.laohu8.com/highlight/detail?id=2524253229","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524253229?lang=en_us&edition=fundamental","pubTime":"2025-04-03 18:40","pubTimestamp":1743676800,"startTime":"0","endTime":"0","summary":"Here are five stocks added to the Zacks Rank #1  List today:. NCR Atleos Corporation NATL: This financial technology company has seen the Zacks Consensus Estimate for its current year earnings increasing 9% over the last 60 days.NCR Atleos Corporation price-consensus-chart | NCR Atleos Corporation Quote. BGC Group, Inc.BGC: This financial brokerage and technology company has seen the Zacks Consensus Estimate for its current year earnings increasing 9.4% over the last 60 days.Naspers Limited NPSNY: Thisconsumer internet company has seen the Zacks Consensus Estimate for its current year earnings increasing 14.6% over the last 60 days.Alexander's, Inc. ALX: This real estate investment trust has seen the Zacks Consensus Estimate for its current year earnings increasing 15% over the last 60 days.Veeva Systems Inc.VEEV: This cloud-based softwareprovider has seen the Zacks Consensus Estimate for its current year earnings increasing 4.5% over the last 60 days.Today, you can download 7 Best Sto","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/strong-buy-stocks-april-3rd-104000857.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VEEV","NATL","BGC","LU0266013472.USD","BK4534","BK4167","BK4585","LU1989764748.USD","LU0058720904.USD","LU0289739699.SGD","BK4122","BK4528","BK4588","BK4127","BK4227","BK4080","BK4231","NPSNY","LU1989764664.SGD","BK4220","BK4613","ALX","LU0170899867.USD","BK4504"],"gpt_icon":1},{"id":"2524924416","title":"Is Alexander's (ALX) Stock Outpacing Its Finance Peers This Year?","url":"https://stock-news.laohu8.com/highlight/detail?id=2524924416","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524924416?lang=en_us&edition=fundamental","pubTime":"2025-04-02 21:40","pubTimestamp":1743601207,"startTime":"0","endTime":"0","summary":"Investors interested in Finance stocks should always be looking to find the best-performing companies in the group. Has Alexander's  been one of those stocks this year?By taking a look at the stock's year-to-date performance in comparison to its Finance peers, we might be able to answer that question.Alexander's is a member of the Finance sector. This group includes 859 individual stocks and currently holds a Zacks Sector Rank of #2. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.Based on the latest available data, ALX has gained about 5.3% so far this year. At the same time, Finance stocks have gained an average of 2.4%. This shows that Alexander's is outperforming its peers so far this year.Another stock in the Finance sector, Banco Bilbao , has outperformed the sector so far this year. The stock's year-to-date return is 41.2%.Banco Bilbao Viscaya ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/alexanders-alx-stock-outpacing-finance-134007588.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4231","BK4207","BBVA","ALX","BK4080"],"gpt_icon":0},{"id":"2523685508","title":"Alexander's (ALX) Upgraded to Strong Buy: Here's Why","url":"https://stock-news.laohu8.com/highlight/detail?id=2523685508","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523685508?lang=en_us&edition=fundamental","pubTime":"2025-03-29 00:00","pubTimestamp":1743177609,"startTime":"0","endTime":"0","summary":"Investors might want to bet on Alexander's , as it has been recently upgraded to a Zacks Rank #1 . This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.The power of a changing earnings picture in determining near-term stock price movements makes the Zacks rating system highly useful for individual investors, since it can be difficult to make decisions based on rating upgrades by Wall Street analysts. These are mostly driven by subjective factors that are hard to see and measure in real time.Therefore, the Zacks rating upgrade for Alexander's basically reflects positivity about its earnings outlook that could translate into buying pressure and an increas","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/alexanders-alx-upgraded-strong-buy-160009127.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ALX"],"gpt_icon":0},{"id":"2522412375","title":"Best Income Stocks to Buy for March 28th","url":"https://stock-news.laohu8.com/highlight/detail?id=2522412375","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522412375?lang=en_us&edition=fundamental","pubTime":"2025-03-28 15:09","pubTimestamp":1743145740,"startTime":"0","endTime":"0","summary":"Here are three stocks with buy rank and strong income characteristics for investors to consider today, March 28:. Alexander's, Inc. ALX: This real estate investment trust witnessed the Zacks Consensus Estimate for its current year earnings increasing 15% the last 60 days.This Zacks Rank #1 company has a dividend yield of 8.5%, compared with the industry average of 4.9%.Hanmi Financial CorporationHAFC: This holding company for Hanmi Bankhas witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.4% the last 60 days.Hanmi Financial Corporation price-consensus-chart | Hanmi Financial Corporation Quote. First Financial Bancorp. FFBC: This bank holding company for First Financial Bank has witnessed the Zacks Consensus Estimate for its next year earnings increasing 5.2% in the last 60 days.First Financial Bancorp. price-consensus-chart | First Financial Bancorp. Quote. This Zacks Rank #1 company has a dividend yield of 3.8%, compared with the industry average of 3.2","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/best-income-stocks-buy-march-070900137.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4080","US5Y.BOND","US2Y.BOND","ALX","US3Y.BOND","US7Y.BOND","BK4231","BK4211","BK4099","FFBC","HAFC","TTM","US6M.BOND","BK4523","US10Y.BOND","US30Y.BOND","US12M.BOND"],"gpt_icon":0},{"id":"2522416120","title":"Best Income Stocks to Buy for March 25th","url":"https://stock-news.laohu8.com/highlight/detail?id=2522416120","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522416120?lang=en_us&edition=fundamental","pubTime":"2025-03-25 16:31","pubTimestamp":1742891460,"startTime":"0","endTime":"0","summary":"Here are three stocks with buy rank and strong income characteristics for investors to consider today, March 25th:. Alexander’s, Inc. ALX: This real estate investment trust has witnessed the Zacks Consensus Estimate for its current year earnings increasing 15% over the last 60 days.This Zacks Rank #1 company has a dividend yield of 8.5%, compared with the industry average of 4.9%.Hanmi Financial Corporation HAFC: This holding company for Hanmi Bank has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.4% over the last 60 days.Hanmi Financial Corporation price-consensus-chart | Hanmi Financial Corporation Quote. Horizon Bancorp, Inc. HBNC: This holding company for Horizon Bank has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.6% over the last 60 days.This Zacks Rank #1 company has a dividend yield of 4.2%, compared with the industry average of 2.9%.Find more top income stocks withsome of our great premium screens.Today,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/best-income-stocks-buy-march-083100788.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4099","US30Y.BOND","BK4523","BK4211","HBNC","BK4231","US2Y.BOND","HAFC","US10Y.BOND","US3Y.BOND","US5Y.BOND","US6M.BOND","ALX","US7Y.BOND","US12M.BOND","BK4080","TTM"],"gpt_icon":0},{"id":"2520575777","title":"Is Alexander's (ALX) Outperforming Other Finance Stocks This Year?","url":"https://stock-news.laohu8.com/highlight/detail?id=2520575777","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520575777?lang=en_us&edition=fundamental","pubTime":"2025-03-17 21:40","pubTimestamp":1742218810,"startTime":"0","endTime":"0","summary":"The Finance group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Alexander's  been one of those stocks this year?Let's take a closer look at the stock's year-to-date performance to find out.Alexander's is a member of the Finance sector. This group includes 868 individual stocks and currently holds a Zacks Sector Rank of #1. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.Based on the latest available data, ALX has gained about 6.2% so far this year. Meanwhile, stocks in the Finance group have gained about 1% on average. This means that Alexander's is outperforming the sector as a whole this year.One other Finance stock that has outperformed the sector so far this year is Banco Bilbao . The stock is up 47.5% year-to-date.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/alexanders-alx-outperforming-other-finance-134010868.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BBVA","ALX"],"gpt_icon":0},{"id":"2518083767","title":"With 73% institutional ownership, Atlas Arteria Limited (ASX:ALX) is a favorite amongst the big guns","url":"https://stock-news.laohu8.com/highlight/detail?id=2518083767","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518083767?lang=en_us&edition=fundamental","pubTime":"2025-03-12 04:53","pubTimestamp":1741726382,"startTime":"0","endTime":"0","summary":"Institutions' substantial holdings in Atlas Arteria implies that they have significant influence over the company's share price. A look at the shareholders of Atlas Arteria Limited  can tell us which group is most powerful. And the group that holds the biggest piece of the pie are institutions with 73% ownership. Put another way, the group faces the maximum upside potential .Because institutional owners have a huge pool of resources and liquidity, their investing decisions tend to carry a great deal of weight, especially with individual investors. As a result, a sizeable amount of institutional money invested in a firm is generally viewed as a positive attribute.In the chart below, we zoom in on the different ownership groups of Atlas Arteria.What Does The Institutional Ownership Tell Us About Atlas Arteria?While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/73-institutional-ownership-atlas-arteria-205302312.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK4080","BK7090","BK4231","ALX.AU","AFH","ALX"],"gpt_icon":0},{"id":"2518602777","title":"Atlas Arteria's (ASX:ALX) Solid Earnings May Rest On Weak Foundations","url":"https://stock-news.laohu8.com/highlight/detail?id=2518602777","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518602777?lang=en_us&edition=fundamental","pubTime":"2025-03-12 04:37","pubTimestamp":1741725422,"startTime":"0","endTime":"0","summary":"Atlas Arteria Limited's  robust recent earnings didn't do much to move the stock. However the statutory profit number doesn't tell the whole story, and we have found some factors which might be of concern to shareholders.To properly understand Atlas Arteria's profit results, we need to consider the AU$31m gain attributed to unusual items. We can't deny that higher profits generally leave us optimistic, but we'd prefer it if the profit were to be sustainable. When we crunched the numbers on thousands of publicly listed companies, we found that a boost from unusual items in a given year is often not repeated the next year. And, after all, that's exactly what the accounting terminology implies. Atlas Arteria had a rather significant contribution from unusual items relative to its profit to December 2024. All else being equal, this would likely have the effect of making the statutory profit a poor guide to underlying earnings power.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/atlas-arterias-asx-alx-solid-203702184.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["AFH","ALX","ALX.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":104,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALX\",params:#limit:5,,,undefined,":[{"date":"2025-05-05","symbol":"ALX","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":3.57,"defaultRemindTime":1746432000000,"name":null,"time":"Pre-Market","dateTimestamp":1746417600000,"actualEps":null},{"date":"2025-02-18","symbol":"ALX","amount":4.5,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-18","defaultRemindTime":1739889000000,"name":"亚历山大公司","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-02-28","payableDate":"2025-02-18","currency":"USD","dateTimestamp":1739854800000,"payDate":"2025-02-28"},{"market":"US","date":"2025-02-10","symbol":"ALX","fiscalQuarterEnding":"2024/12","expectedEps":3.71,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1739163600000,"reportTimeType":"pre","actualEps":4.06},{"date":"2024-11-08","symbol":"ALX","amount":4.5,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-11-11","defaultRemindTime":1731076200000,"name":"亚历山大公司","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-11-29","payableDate":"2024-11-11","currency":"USD","dateTimestamp":1731042000000,"payDate":"2024-11-29"},{"date":"2024-11-04","symbol":"ALX","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2024/09","expectedEps":2.57,"defaultRemindTime":1730710800000,"name":null,"time":"Pre-Market","dateTimestamp":1730696400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALX\",market:\"US\",,,undefined,":[{"executeDate":"2015-05-08","recordDate":"2015-05-12","paymentDate":"2015-05-22","value":3.5,"currency":"USD"},{"executeDate":"2015-08-07","recordDate":"2015-08-11","paymentDate":"2015-08-21","value":3.5,"currency":"USD"},{"executeDate":"2015-11-06","recordDate":"2015-11-10","paymentDate":"2015-11-23","value":3.5,"currency":"USD"},{"executeDate":"2016-01-28","recordDate":"2016-02-01","paymentDate":"2016-02-16","value":4,"currency":"USD"},{"executeDate":"2016-05-06","recordDate":"2016-05-10","paymentDate":"2016-05-20","value":4,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":0,"sell":1,"strongSell":0,"meanLabel":"SELL","meanPercent":1,"analysts":1,"updateTime":1745899200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALX","date":"2025-04-28","current":23.583773,"percent":0.679935,"low":8.415334,"twenty":9.848341,"median":18.140309,"eighty":25.985661,"high":39.726508,"avg":18.784879,"sd":8.598862,"marketCap":1024573446},"quantilePoints":[{"date":"2020-05-01","current":26.037615,"twenty":26.322342,"median":30.632099,"eighty":37.240512,"marketCap":1564209708},{"date":"2020-05-08","current":27.573602,"twenty":26.354458,"median":30.625733,"eighty":37.073238,"marketCap":1289948235},{"date":"2020-05-15","current":24.577919,"twenty":26.297153,"median":30.608168,"eighty":36.976395,"marketCap":1149804197},{"date":"2020-05-22","current":26.416377,"twenty":26.250436,"median":30.556909,"eighty":36.866347,"marketCap":1235810961},{"date":"2020-05-29","current":28.367283,"twenty":26.250436,"median":30.545421,"eighty":36.831131,"marketCap":1327078233},{"date":"2020-06-05","current":31.189382,"twenty":26.250436,"median":30.538939,"eighty":36.831131,"marketCap":1459101680},{"date":"2020-06-12","current":28.195883,"twenty":26.250436,"median":30.508042,"eighty":36.831131,"marketCap":1319059788},{"date":"2020-06-19","current":28.086711,"twenty":26.250436,"median":30.480241,"eighty":36.740947,"marketCap":1313952498},{"date":"2020-06-26","current":25.984056,"twenty":26.194509,"median":30.447728,"eighty":36.597883,"marketCap":1215586092},{"date":"2020-07-02","current":26.603062,"twenty":26.194509,"median":30.422472,"eighty":36.597883,"marketCap":1244544427},{"date":"2020-07-10","current":26.128163,"twenty":26.128163,"median":30.397493,"eighty":36.581247,"marketCap":1222327715},{"date":"2020-07-17","current":26.915294,"twenty":26.117683,"median":30.365121,"eighty":36.371641,"marketCap":1259151276},{"date":"2020-07-24","current":27.105253,"twenty":26.117683,"median":30.338077,"eighty":36.274385,"marketCap":1268037961},{"date":"2020-07-31","current":27.488447,"twenty":26.117683,"median":30.30968,"eighty":36.274385,"marketCap":1285964549},{"date":"2020-08-07","current":27.405101,"twenty":26.117683,"median":30.294521,"eighty":36.274385,"marketCap":1310785978},{"date":"2020-08-14","current":27.666712,"twenty":26.117683,"median":30.26978,"eighty":36.274385,"marketCap":1323298839},{"date":"2020-08-21","current":27.60478,"twenty":26.117683,"median":30.249795,"eighty":36.274385,"marketCap":1320336610},{"date":"2020-08-28","current":27.977442,"twenty":26.117683,"median":30.220439,"eighty":36.274385,"marketCap":1338161052},{"date":"2020-09-04","current":28.410969,"twenty":26.117683,"median":30.215847,"eighty":36.274385,"marketCap":1358896650},{"date":"2020-09-11","current":26.696081,"twenty":26.117683,"median":30.215847,"eighty":36.274385,"marketCap":1276873572},{"date":"2020-09-18","current":27.40083,"twenty":26.117683,"median":30.191447,"eighty":36.274385,"marketCap":1310581686},{"date":"2020-09-25","current":26.229453,"twenty":26.061419,"median":30.167383,"eighty":36.274385,"marketCap":1254554715},{"date":"2020-10-02","current":27.190473,"twenty":26.061419,"median":30.134313,"eighty":36.274385,"marketCap":1300520325},{"date":"2020-10-09","current":26.854116,"twenty":26.061419,"median":30.122376,"eighty":36.274385,"marketCap":1284432362},{"date":"2020-10-16","current":26.053265,"twenty":26.058018,"median":30.110463,"eighty":36.274385,"marketCap":1246127687},{"date":"2020-10-23","current":26.231588,"twenty":26.0566,"median":30.064018,"eighty":36.274385,"marketCap":1254656861},{"date":"2020-10-30","current":25.967841,"twenty":26.037615,"median":30.037298,"eighty":36.274385,"marketCap":1242041855},{"date":"2020-11-06","current":32.03616,"twenty":26.037615,"median":30.037298,"eighty":36.274385,"marketCap":1215483947},{"date":"2020-11-13","current":36.997935,"twenty":26.037615,"median":30.037298,"eighty":36.371641,"marketCap":1403738656},{"date":"2020-11-20","current":38.630771,"twenty":26.037615,"median":30.054698,"eighty":36.597883,"marketCap":1465690084},{"date":"2020-11-27","current":38.035789,"twenty":26.037615,"median":30.054698,"eighty":36.910628,"marketCap":1443115862},{"date":"2020-12-04","current":38.033097,"twenty":26.037615,"median":30.059099,"eighty":36.997935,"marketCap":1443013716},{"date":"2020-12-11","current":37.687145,"twenty":26.037615,"median":30.074161,"eighty":37.096201,"marketCap":1429887981},{"date":"2020-12-18","current":37.333117,"twenty":26.037615,"median":30.091732,"eighty":37.638685,"marketCap":1416455808},{"date":"2020-12-24","current":36.950821,"twenty":26.037615,"median":30.091732,"eighty":37.638685,"marketCap":1401951105},{"date":"2020-12-31","current":37.334464,"twenty":26.037615,"median":30.091732,"eighty":37.638685,"marketCap":1416506881},{"date":"2021-01-08","current":36.400261,"twenty":26.037615,"median":30.11363,"eighty":37.638685,"marketCap":1381062288},{"date":"2021-01-15","current":37.171584,"twenty":26.037615,"median":30.127921,"eighty":37.638685,"marketCap":1410327060},{"date":"2021-01-22","current":37.648108,"twenty":26.037615,"median":30.134684,"eighty":37.648108,"marketCap":1428406867},{"date":"2021-01-29","current":35.968158,"twenty":26.037615,"median":30.184406,"eighty":37.648108,"marketCap":1364667888},{"date":"2021-02-05","current":35.751434,"twenty":26.037615,"median":30.215847,"eighty":37.648108,"marketCap":1356445151},{"date":"2021-02-12","current":36.113538,"twenty":26.037615,"median":30.255189,"eighty":37.648108,"marketCap":1370183761},{"date":"2021-02-19","current":32.06685,"twenty":26.037615,"median":30.25985,"eighty":37.648108,"marketCap":1344851602},{"date":"2021-02-26","current":33.015508,"twenty":26.037615,"median":30.25985,"eighty":37.648108,"marketCap":1384637391},{"date":"2021-03-05","current":35.029733,"twenty":26.037615,"median":30.276188,"eighty":37.648108,"marketCap":1469111968},{"date":"2021-03-12","current":37.434868,"twenty":26.037615,"median":30.322139,"eighty":37.648108,"marketCap":1569980946},{"date":"2021-03-19","current":35.270855,"twenty":26.037615,"median":30.343606,"eighty":37.648108,"marketCap":1479224402},{"date":"2021-03-26","current":35.116196,"twenty":26.040222,"median":30.389165,"eighty":37.6473,"marketCap":1472738144},{"date":"2021-04-01","current":34.631516,"twenty":26.040222,"median":30.417872,"eighty":37.6473,"marketCap":1452411130},{"date":"2021-04-09","current":34.961537,"twenty":26.037615,"median":30.480241,"eighty":37.648108,"marketCap":1466251886},{"date":"2021-04-16","current":34.61812,"twenty":26.037615,"median":30.508042,"eighty":37.648108,"marketCap":1451849328},{"date":"2021-04-23","current":34.018967,"twenty":26.037615,"median":30.546126,"eighty":37.648108,"marketCap":1426721461},{"date":"2021-04-30","current":33.762013,"twenty":26.037615,"median":30.579475,"eighty":37.648108,"marketCap":1415945079},{"date":"2021-05-07","current":25.421361,"twenty":25.985994,"median":30.579475,"eighty":37.648108,"marketCap":1404504750},{"date":"2021-05-14","current":24.72158,"twenty":25.974747,"median":30.579475,"eighty":37.648108,"marketCap":1365842564},{"date":"2021-05-21","current":24.456273,"twenty":25.909875,"median":30.579475,"eighty":37.648108,"marketCap":1351184642},{"date":"2021-05-28","current":25.066386,"twenty":25.883567,"median":30.579475,"eighty":37.648108,"marketCap":1384892756},{"date":"2021-06-04","current":25.627505,"twenty":25.862129,"median":30.579475,"eighty":37.648108,"marketCap":1415894006},{"date":"2021-06-11","current":26.058281,"twenty":25.862129,"median":30.579475,"eighty":37.648108,"marketCap":1439693978},{"date":"2021-06-18","current":25.148659,"twenty":25.826122,"median":30.579475,"eighty":37.648108,"marketCap":1389438244},{"date":"2021-06-25","current":25.283623,"twenty":25.759615,"median":30.579475,"eighty":37.648108,"marketCap":1396894887},{"date":"2021-07-02","current":25.316902,"twenty":25.700662,"median":30.579475,"eighty":37.648108,"marketCap":1398733512},{"date":"2021-07-09","current":24.960078,"twenty":25.676179,"median":30.579475,"eighty":37.648108,"marketCap":1379019372},{"date":"2021-07-16","current":25.096892,"twenty":25.641371,"median":30.556909,"eighty":37.648108,"marketCap":1386578162},{"date":"2021-07-23","current":25.984328,"twenty":25.607509,"median":30.542831,"eighty":37.648108,"marketCap":1435608146},{"date":"2021-07-30","current":25.776335,"twenty":25.607509,"median":30.48518,"eighty":37.648108,"marketCap":1424116743},{"date":"2021-08-06","current":20.27375,"twenty":25.528687,"median":30.420037,"eighty":37.648108,"marketCap":1395158409},{"date":"2021-08-13","current":20.111958,"twenty":25.477334,"median":30.363964,"eighty":37.648108,"marketCap":1384024517},{"date":"2021-08-20","current":19.798764,"twenty":25.417663,"median":30.337207,"eighty":37.648108,"marketCap":1362471753},{"date":"2021-08-27","current":19.861106,"twenty":25.354942,"median":30.276994,"eighty":37.648108,"marketCap":1366761876},{"date":"2021-09-03","current":19.143431,"twenty":25.318751,"median":30.219265,"eighty":37.648108,"marketCap":1317374382},{"date":"2021-09-10","current":18.837659,"twenty":25.308582,"median":30.185688,"eighty":37.648108,"marketCap":1296332347},{"date":"2021-09-17","current":19.033591,"twenty":25.235494,"median":30.170346,"eighty":37.648108,"marketCap":1309815593},{"date":"2021-09-24","current":19.544201,"twenty":25.222319,"median":30.134684,"eighty":37.648108,"marketCap":1344953748},{"date":"2021-10-01","current":19.603574,"twenty":25.151895,"median":30.117581,"eighty":37.648108,"marketCap":1349039580},{"date":"2021-10-08","current":20.140161,"twenty":25.096575,"median":30.113244,"eighty":37.6473,"marketCap":1385965287},{"date":"2021-10-15","current":20.607725,"twenty":25.051408,"median":30.113244,"eighty":37.6473,"marketCap":1418141214},{"date":"2021-10-22","current":21.209622,"twenty":24.995785,"median":30.113244,"eighty":37.6473,"marketCap":1459561336},{"date":"2021-10-29","current":20.690106,"twenty":24.963667,"median":30.113244,"eighty":37.6473,"marketCap":1423810306},{"date":"2021-11-05","current":19.366809,"twenty":24.945167,"median":30.113244,"eighty":37.6473,"marketCap":1425648930},{"date":"2021-11-12","current":18.756263,"twenty":24.913281,"median":30.10906,"eighty":37.6473,"marketCap":1380704778},{"date":"2021-11-19","current":18.593219,"twenty":24.817199,"median":30.084263,"eighty":37.6473,"marketCap":1368702647},{"date":"2021-11-26","current":18.198445,"twenty":24.790519,"median":30.063977,"eighty":37.6473,"marketCap":1339642167},{"date":"2021-12-03","current":17.86542,"twenty":24.737664,"median":30.013258,"eighty":37.6473,"marketCap":1315127175},{"date":"2021-12-10","current":17.9348,"twenty":24.677054,"median":29.956609,"eighty":37.6473,"marketCap":1320234465},{"date":"2021-12-17","current":17.531701,"twenty":24.637964,"median":29.898751,"eighty":37.6473,"marketCap":1290561110},{"date":"2021-12-23","current":18.045115,"twenty":24.605621,"median":29.859705,"eighty":37.6473,"marketCap":1328355056},{"date":"2021-12-31","current":18.059685,"twenty":24.57798,"median":29.830385,"eighty":37.6473,"marketCap":1329427587},{"date":"2022-01-07","current":18.751406,"twenty":24.515544,"median":29.783954,"eighty":37.646493,"marketCap":1380347268},{"date":"2022-01-14","current":18.211628,"twenty":24.496208,"median":29.722422,"eighty":37.645685,"marketCap":1340612552},{"date":"2022-01-21","current":17.671155,"twenty":24.46396,"median":29.656299,"eighty":37.645685,"marketCap":1300826763},{"date":"2022-01-28","current":18.536327,"twenty":24.424649,"median":29.571808,"eighty":37.645685,"marketCap":1364514669},{"date":"2022-02-04","current":17.950064,"twenty":24.289124,"median":29.388132,"eighty":37.645685,"marketCap":1321358068},{"date":"2022-02-11","current":17.966022,"twenty":24.215767,"median":29.314662,"eighty":37.645685,"marketCap":1322532745},{"date":"2022-02-18","current":9.944481,"twenty":24.136487,"median":29.111039,"eighty":37.645685,"marketCap":1321919870},{"date":"2022-02-25","current":9.879934,"twenty":24.08546,"median":28.862924,"eighty":37.645685,"marketCap":1313339623},{"date":"2022-03-04","current":9.677072,"twenty":23.907668,"median":28.45635,"eighty":37.644878,"marketCap":1286373132},{"date":"2022-03-11","current":9.64134,"twenty":23.807186,"median":28.356996,"eighty":37.644878,"marketCap":1281623352},{"date":"2022-03-18","current":9.61944,"twenty":23.761532,"median":28.215548,"eighty":37.644878,"marketCap":1278712197},{"date":"2022-03-25","current":9.64403,"twenty":23.715509,"median":28.056688,"eighty":37.644878,"marketCap":1281980862},{"date":"2022-04-01","current":10.02747,"twenty":23.67445,"median":27.933376,"eighty":37.644878,"marketCap":1332951617},{"date":"2022-04-08","current":9.896071,"twenty":23.608774,"median":27.831153,"eighty":37.644878,"marketCap":1315484685},{"date":"2022-04-14","current":10.065507,"twenty":23.533919,"median":27.795767,"eighty":37.644878,"marketCap":1338007834},{"date":"2022-04-22","current":10.002881,"twenty":23.4598,"median":27.694475,"eighty":37.644878,"marketCap":1329682951},{"date":"2022-04-29","current":9.534914,"twenty":23.403723,"median":27.610989,"eighty":37.644878,"marketCap":1267476159},{"date":"2022-05-06","current":9.504731,"twenty":23.264889,"median":27.610989,"eighty":37.644878,"marketCap":1231622983},{"date":"2022-05-13","current":9.226861,"twenty":23.197613,"median":27.610989,"eighty":37.644878,"marketCap":1195616589},{"date":"2022-05-20","current":9.173651,"twenty":23.083917,"median":27.610989,"eighty":37.644878,"marketCap":1188721747},{"date":"2022-05-27","current":9.79206,"twenty":22.99881,"median":27.610989,"eighty":37.644878,"marketCap":1268855127},{"date":"2022-06-03","current":9.41999,"twenty":22.94787,"median":27.610989,"eighty":37.644878,"marketCap":1220642310},{"date":"2022-06-10","current":9.099553,"twenty":22.871079,"median":27.610989,"eighty":37.644878,"marketCap":1179120042},{"date":"2022-06-17","current":8.533171,"twenty":22.825702,"median":27.610989,"eighty":37.644878,"marketCap":1105728285},{"date":"2022-06-24","current":8.881592,"twenty":22.739152,"median":27.617198,"eighty":37.645685,"marketCap":1150876728},{"date":"2022-07-01","current":9.027425,"twenty":22.636542,"median":27.617198,"eighty":37.645685,"marketCap":1169773701},{"date":"2022-07-08","current":9.052256,"twenty":22.375092,"median":27.617198,"eighty":37.645685,"marketCap":1172991294},{"date":"2022-07-15","current":9.284405,"twenty":21.948776,"median":27.617198,"eighty":37.645685,"marketCap":1203073232},{"date":"2022-07-22","current":9.164192,"twenty":21.23723,"median":27.617198,"eighty":37.645685,"marketCap":1187495997},{"date":"2022-07-29","current":9.597748,"twenty":20.878022,"median":27.617198,"eighty":37.645685,"marketCap":1243676187},{"date":"2022-08-05","current":10.71662,"twenty":20.633701,"median":27.617198,"eighty":37.645685,"marketCap":1269876585},{"date":"2022-08-12","current":11.21185,"twenty":20.559484,"median":27.617198,"eighty":37.645685,"marketCap":1328559347},{"date":"2022-08-19","current":10.914453,"twenty":20.345245,"median":27.617198,"eighty":37.645685,"marketCap":1293319046},{"date":"2022-08-26","current":10.305006,"twenty":20.136301,"median":27.617198,"eighty":37.645685,"marketCap":1221101966},{"date":"2022-09-02","current":9.847274,"twenty":20.019039,"median":27.617198,"eighty":37.645685,"marketCap":1166862546},{"date":"2022-09-09","current":10.031746,"twenty":19.939479,"median":27.617198,"eighty":37.645685,"marketCap":1188721747},{"date":"2022-09-16","current":9.998989,"twenty":19.843294,"median":27.617198,"eighty":37.645685,"marketCap":1184840207},{"date":"2022-09-23","current":9.378335,"twenty":19.759132,"median":27.617198,"eighty":37.645685,"marketCap":1111295231},{"date":"2022-09-30","current":9.006374,"twenty":19.642464,"median":27.617198,"eighty":37.645685,"marketCap":1067219318},{"date":"2022-10-07","current":8.921896,"twenty":19.537967,"median":27.617198,"eighty":37.645685,"marketCap":1057209030},{"date":"2022-10-14","current":8.760699,"twenty":19.442519,"median":27.617198,"eighty":37.645685,"marketCap":1038107765},{"date":"2022-10-21","current":9.510655,"twenty":19.190965,"median":27.617198,"eighty":37.645685,"marketCap":1126974611},{"date":"2022-10-28","current":9.937786,"twenty":19.119077,"median":27.617198,"eighty":37.645685,"marketCap":1177587855},{"date":"2022-11-04","current":9.8356,"twenty":19.005717,"median":27.617198,"eighty":37.645685,"marketCap":1201949628},{"date":"2022-11-11","current":9.965994,"twenty":18.837571,"median":27.617198,"eighty":37.645685,"marketCap":1217884373},{"date":"2022-11-18","current":10.192095,"twenty":18.788871,"median":27.617198,"eighty":37.645685,"marketCap":1245514812},{"date":"2022-11-25","current":10.126898,"twenty":18.732674,"median":27.617198,"eighty":37.645685,"marketCap":1237547439},{"date":"2022-12-02","current":10.04373,"twenty":18.522451,"median":27.617198,"eighty":37.645685,"marketCap":1227383932},{"date":"2022-12-09","current":9.77082,"twenty":18.355106,"median":27.617198,"eighty":37.645685,"marketCap":1194033329},{"date":"2022-12-16","current":9.527166,"twenty":18.229944,"median":27.617198,"eighty":37.645685,"marketCap":1164257828},{"date":"2022-12-23","current":9.088338,"twenty":18.192062,"median":27.617198,"eighty":37.645685,"marketCap":1110631283},{"date":"2022-12-30","current":9.197,"twenty":18.103811,"median":27.617198,"eighty":37.645685,"marketCap":1123910237},{"date":"2023-01-06","current":9.273482,"twenty":18.039842,"median":27.617198,"eighty":37.645685,"marketCap":1133256578},{"date":"2023-01-13","current":9.587766,"twenty":17.95506,"median":27.617198,"eighty":37.645685,"marketCap":1171663398},{"date":"2023-01-20","current":9.685562,"twenty":17.872497,"median":27.617198,"eighty":37.645685,"marketCap":1183614457},{"date":"2023-01-27","current":9.881572,"twenty":17.744144,"median":27.617198,"eighty":37.645685,"marketCap":1207567647},{"date":"2023-02-03","current":9.892856,"twenty":17.683921,"median":27.617198,"eighty":37.645685,"marketCap":1208946615},{"date":"2023-02-10","current":9.499165,"twenty":17.405706,"median":27.617198,"eighty":37.645685,"marketCap":1160835944},{"date":"2023-02-17","current":19.975608,"twenty":17.405706,"median":27.617198,"eighty":37.645685,"marketCap":1151234238},{"date":"2023-02-24","current":19.575936,"twenty":17.405706,"median":27.617198,"eighty":37.645685,"marketCap":1128200361},{"date":"2023-03-03","current":18.135878,"twenty":17.405706,"median":27.617198,"eighty":37.645685,"marketCap":1045206898},{"date":"2023-03-10","current":17.361348,"twenty":17.359276,"median":27.617198,"eighty":37.645685,"marketCap":1000569183},{"date":"2023-03-17","current":16.826089,"twenty":17.061815,"median":27.617198,"eighty":37.645685,"marketCap":969721152},{"date":"2023-03-24","current":16.893439,"twenty":16.820772,"median":27.617198,"eighty":37.645685,"marketCap":973602692},{"date":"2023-03-31","current":17.169931,"twenty":16.675791,"median":27.610989,"eighty":37.644878,"marketCap":989537437},{"date":"2023-04-06","current":17.278046,"twenty":16.675791,"median":27.610989,"eighty":37.644878,"marketCap":995768331},{"date":"2023-04-14","current":17.352486,"twenty":16.670828,"median":27.617198,"eighty":37.645685,"marketCap":1000058454},{"date":"2023-04-21","current":16.687843,"twenty":16.638394,"median":27.617198,"eighty":37.645685,"marketCap":961753779},{"date":"2023-04-28","current":16.227911,"twenty":16.158079,"median":27.617198,"eighty":37.645685,"marketCap":935246944},{"date":"2023-05-05","current":16.59968,"twenty":16.158079,"median":27.504978,"eighty":37.398855,"marketCap":901794195},{"date":"2023-05-12","current":16.059111,"twenty":16.01682,"median":27.40083,"eighty":37.188545,"marketCap":872427277},{"date":"2023-05-19","current":15.791177,"twenty":15.825586,"median":27.193683,"eighty":37.094214,"marketCap":857871501},{"date":"2023-05-26","current":14.904645,"twenty":15.133846,"median":27.0901,"eighty":37.056473,"marketCap":809709756},{"date":"2023-06-02","current":15.770495,"twenty":15.032689,"median":26.890421,"eighty":36.951157,"marketCap":856747897},{"date":"2023-06-09","current":17.663894,"twenty":15.032689,"median":26.801902,"eighty":36.794941,"marketCap":959608718},{"date":"2023-06-16","current":17.533218,"twenty":15.032689,"median":26.703284,"eighty":36.662852,"marketCap":952509585},{"date":"2023-06-23","current":16.973847,"twenty":14.990008,"median":26.585492,"eighty":36.574407,"marketCap":922121209},{"date":"2023-06-30","current":17.379038,"twenty":14.947326,"median":26.449939,"eighty":36.537897,"marketCap":944133629},{"date":"2023-07-07","current":16.877015,"twenty":14.947326,"median":26.43057,"eighty":36.47672,"marketCap":916860700},{"date":"2023-07-14","current":17.377158,"twenty":14.947326,"median":26.385809,"eighty":36.371442,"marketCap":944031483},{"date":"2023-07-21","current":17.617828,"twenty":14.947326,"median":26.28756,"eighty":36.268341,"marketCap":957106146},{"date":"2023-07-28","current":17.616888,"twenty":14.947326,"median":26.231588,"eighty":36.0463,"marketCap":957055073},{"date":"2023-08-04","current":9.501247,"twenty":11.197368,"median":26.169656,"eighty":35.826789,"marketCap":984889803},{"date":"2023-08-11","current":9.52539,"twenty":11.030998,"median":26.116266,"eighty":35.718641,"marketCap":987392375},{"date":"2023-08-18","current":9.038601,"twenty":10.768599,"median":26.061419,"eighty":35.590921,"marketCap":936932350},{"date":"2023-08-25","current":9.162762,"twenty":10.618867,"median":26.050651,"eighty":35.278738,"marketCap":949802721},{"date":"2023-09-01","current":9.447543,"twenty":10.256585,"median":25.984328,"eighty":35.074049,"marketCap":979322857},{"date":"2023-09-08","current":9.652507,"twenty":10.226867,"median":25.978597,"eighty":34.954474,"marketCap":1000569183},{"date":"2023-09-15","current":9.823474,"twenty":10.201541,"median":25.887756,"eighty":34.844385,"marketCap":1018291480},{"date":"2023-09-22","current":9.39039,"twenty":10.11805,"median":25.873875,"eighty":34.611544,"marketCap":973398401},{"date":"2023-09-29","current":8.900152,"twenty":10.034143,"median":25.776335,"eighty":34.475638,"marketCap":922580865},{"date":"2023-10-06","current":8.415334,"twenty":10.023628,"median":25.707929,"eighty":34.335105,"marketCap":872325132},{"date":"2023-10-13","current":8.758747,"twenty":9.99942,"median":25.50797,"eighty":34.243624,"marketCap":907922943},{"date":"2023-10-20","current":8.684349,"twenty":9.98313,"median":25.390301,"eighty":34.059154,"marketCap":900210935},{"date":"2023-10-27","current":9.0657,"twenty":9.969837,"median":25.339088,"eighty":34.020705,"marketCap":939741360},{"date":"2023-11-03","current":10.098963,"twenty":9.956016,"median":25.308582,"eighty":33.960714,"marketCap":1002867464},{"date":"2023-11-10","current":9.729176,"twenty":9.938005,"median":25.148659,"eighty":33.799584,"marketCap":966146049},{"date":"2023-11-17","current":9.86341,"twenty":9.925976,"median":25.072857,"eighty":33.703336,"marketCap":979476076},{"date":"2023-11-24","current":9.575397,"twenty":9.914672,"median":24.960078,"eighty":33.469739,"marketCap":950875252},{"date":"2023-12-01","current":9.461221,"twenty":9.895298,"median":24.815914,"eighty":33.313738,"marketCap":939537068},{"date":"2023-12-08","current":9.768263,"twenty":9.880415,"median":24.739605,"eighty":33.129347,"marketCap":970027589},{"date":"2023-12-15","current":10.316516,"twenty":9.874171,"median":24.573661,"eighty":33.01605,"marketCap":1024471301},{"date":"2023-12-22","current":10.902828,"twenty":9.874171,"median":24.496023,"eighty":32.904734,"marketCap":1082694407},{"date":"2023-12-29","current":11.203698,"twenty":9.874043,"median":24.456273,"eighty":32.891541,"marketCap":1112572053},{"date":"2024-01-05","current":11.107523,"twenty":9.873915,"median":24.336941,"eighty":32.801333,"marketCap":1103021421},{"date":"2024-01-12","current":11.151753,"twenty":9.873915,"median":23.803414,"eighty":32.686536,"marketCap":1107413690},{"date":"2024-01-19","current":11.215013,"twenty":9.873787,"median":23.459953,"eighty":32.644586,"marketCap":1113695657},{"date":"2024-01-26","current":11.787953,"twenty":9.873915,"median":22.554966,"eighty":32.567312,"marketCap":1170590868},{"date":"2024-02-02","current":11.508169,"twenty":9.873915,"median":21.38352,"eighty":32.49313,"marketCap":1142807210},{"date":"2024-02-09","current":11.151239,"twenty":9.873915,"median":20.871194,"eighty":32.418215,"marketCap":1107362617},{"date":"2024-02-16","current":11.596665,"twenty":9.873915,"median":20.620596,"eighty":32.312324,"marketCap":1187649216},{"date":"2024-02-23","current":10.819697,"twenty":9.873915,"median":20.54427,"eighty":32.291695,"marketCap":1108077638},{"date":"2024-03-01","current":11.023664,"twenty":9.874043,"median":20.327425,"eighty":32.247589,"marketCap":1128966454},{"date":"2024-03-08","current":10.711979,"twenty":9.874043,"median":20.130512,"eighty":32.096903,"marketCap":1097045892},{"date":"2024-03-15","current":10.40578,"twenty":9.874043,"median":20.006571,"eighty":32.081206,"marketCap":1065687131},{"date":"2024-03-22","current":10.861588,"twenty":9.874043,"median":19.947197,"eighty":32.003396,"marketCap":1112367762},{"date":"2024-03-28","current":10.767334,"twenty":9.874043,"median":19.881145,"eighty":31.971192,"marketCap":1102714983},{"date":"2024-04-05","current":10.771324,"twenty":9.873915,"median":19.782808,"eighty":31.822976,"marketCap":1103123567},{"date":"2024-04-12","current":11.13587,"twenty":9.873915,"median":19.742359,"eighty":31.730038,"marketCap":1140457857},{"date":"2024-04-19","current":10.246197,"twenty":9.873915,"median":19.589755,"eighty":31.597071,"marketCap":1049343803},{"date":"2024-04-26","current":10.548905,"twenty":9.874043,"median":19.530741,"eighty":31.546683,"marketCap":1080345053},{"date":"2024-05-03","current":10.834159,"twenty":9.874043,"median":19.495857,"eighty":31.397883,"marketCap":1109558752},{"date":"2024-05-10","current":11.152205,"twenty":9.874043,"median":19.342332,"eighty":31.233993,"marketCap":1196586974},{"date":"2024-05-17","current":10.383465,"twenty":9.874043,"median":19.168382,"eighty":31.148399,"marketCap":1114104240},{"date":"2024-05-24","current":9.986481,"twenty":9.874043,"median":19.039528,"eighty":30.871949,"marketCap":1071509442},{"date":"2024-05-31","current":9.995525,"twenty":9.874043,"median":18.99285,"eighty":30.746965,"marketCap":1072479827},{"date":"2024-06-07","current":10.132613,"twenty":9.874043,"median":18.837659,"eighty":30.422227,"marketCap":1087188822},{"date":"2024-06-14","current":10.210677,"twenty":9.873915,"median":18.799625,"eighty":30.213387,"marketCap":1095564777},{"date":"2024-06-21","current":10.380609,"twenty":9.873787,"median":18.732674,"eighty":30.133688,"marketCap":1113797803},{"date":"2024-06-28","current":10.558157,"twenty":9.87056,"median":18.581772,"eighty":30.076181,"marketCap":1132847994},{"date":"2024-07-05","current":10.774261,"twenty":9.87056,"median":18.471804,"eighty":29.965976,"marketCap":1156035091},{"date":"2024-07-12","current":10.710001,"twenty":9.87056,"median":18.301823,"eighty":29.889567,"marketCap":1149140250},{"date":"2024-07-15","current":10.691913,"twenty":9.87056,"median":18.272336,"eighty":29.874322,"marketCap":1147199479},{"date":"2024-08-02","current":11.190285,"twenty":9.851543,"median":18.198445,"eighty":29.73032,"marketCap":1200672806},{"date":"2024-08-09","current":21.859784,"twenty":9.851543,"median":18.182488,"eighty":29.659605,"marketCap":1126412809},{"date":"2024-08-16","current":21.87366,"twenty":9.851543,"median":18.182488,"eighty":29.452051,"marketCap":1127127830},{"date":"2024-08-23","current":22.505022,"twenty":9.851543,"median":18.182488,"eighty":29.319621,"marketCap":1159661267},{"date":"2024-08-30","current":22.68442,"twenty":9.851543,"median":18.182488,"eighty":28.935171,"marketCap":1168905462},{"date":"2024-09-06","current":22.780561,"twenty":9.851543,"median":18.182488,"eighty":28.707463,"marketCap":1173859533},{"date":"2024-09-13","current":23.579427,"twenty":9.851543,"median":18.182488,"eighty":28.38848,"marketCap":1215024291},{"date":"2024-09-20","current":24.421903,"twenty":9.851543,"median":18.182488,"eighty":28.33356,"marketCap":1258436256},{"date":"2024-09-27","current":23.523923,"twenty":9.851543,"median":18.182488,"eighty":28.117279,"marketCap":1212164208},{"date":"2024-10-04","current":22.722083,"twenty":9.851543,"median":18.182488,"eighty":27.986625,"marketCap":1170846232},{"date":"2024-10-11","current":22.564491,"twenty":9.851543,"median":18.182488,"eighty":27.912071,"marketCap":1162725641},{"date":"2024-10-18","current":22.773623,"twenty":9.851543,"median":18.182488,"eighty":27.815563,"marketCap":1173502023},{"date":"2024-10-25","current":22.46934,"twenty":9.851543,"median":18.182488,"eighty":27.716685,"marketCap":1157822643},{"date":"2024-10-31","current":22.796419,"twenty":9.851543,"median":18.182488,"eighty":27.678672,"marketCap":1174676700},{"date":"2024-11-08","current":24.993465,"twenty":9.850476,"median":18.163614,"eighty":27.579239,"marketCap":1186014883},{"date":"2024-11-15","current":23.435006,"twenty":9.850476,"median":18.163614,"eighty":27.403361,"marketCap":1112061324},{"date":"2024-11-22","current":23.595372,"twenty":9.850476,"median":18.163614,"eighty":27.24507,"marketCap":1119671186},{"date":"2024-11-29","current":24.066784,"twenty":9.850476,"median":18.163614,"eighty":27.153026,"marketCap":1142041116},{"date":"2024-12-06","current":23.720221,"twenty":9.850476,"median":18.163614,"eighty":26.947172,"marketCap":1125595643},{"date":"2024-12-13","current":22.693446,"twenty":9.850476,"median":18.163614,"eighty":26.835536,"marketCap":1076872096},{"date":"2024-12-20","current":21.627925,"twenty":9.850476,"median":18.163614,"eighty":26.717132,"marketCap":1026309925},{"date":"2024-12-27","current":21.773223,"twenty":9.850476,"median":18.163614,"eighty":26.610165,"marketCap":1033204767},{"date":"2025-01-03","current":21.118843,"twenty":9.850476,"median":18.163614,"eighty":26.540792,"marketCap":1002152443},{"date":"2025-01-10","current":20.314859,"twenty":9.849408,"median":18.14474,"eighty":26.438037,"marketCap":964000987},{"date":"2025-01-17","current":20.538726,"twenty":9.849408,"median":18.14474,"eighty":26.404821,"marketCap":974624150},{"date":"2025-01-24","current":20.745372,"twenty":9.849408,"median":18.14474,"eighty":26.317306,"marketCap":984430147},{"date":"2025-01-31","current":20.626981,"twenty":9.849408,"median":18.14474,"eighty":26.261998,"marketCap":978812128},{"date":"2025-02-07","current":21.14575,"twenty":9.849408,"median":18.14474,"eighty":26.188523,"marketCap":1003429266},{"date":"2025-02-14","current":24.028151,"twenty":9.849408,"median":18.14474,"eighty":26.132066,"marketCap":1043879003},{"date":"2025-02-21","current":24.079878,"twenty":9.849408,"median":18.14474,"eighty":26.090719,"marketCap":1046126210},{"date":"2025-02-28","current":25.401256,"twenty":9.849408,"median":18.14474,"eighty":26.061755,"marketCap":1103532150},{"date":"2025-03-07","current":25.505884,"twenty":9.848341,"median":18.140309,"eighty":26.036074,"marketCap":1108077638},{"date":"2025-03-14","current":24.805225,"twenty":9.848341,"median":18.140309,"eighty":25.985661,"marketCap":1077638190},{"date":"2025-03-21","current":25.23432,"twenty":9.848341,"median":18.140309,"eighty":25.985661,"marketCap":1096279798},{"date":"2025-03-28","current":24.969809,"twenty":9.848341,"median":18.140309,"eighty":25.985661,"marketCap":1084788396},{"date":"2025-04-04","current":23.959966,"twenty":9.848341,"median":18.140309,"eighty":25.985661,"marketCap":1040916774},{"date":"2025-04-11","current":23.428594,"twenty":9.849408,"median":18.14474,"eighty":25.985328,"marketCap":1017831824},{"date":"2025-04-17","current":23.376867,"twenty":9.849408,"median":18.14474,"eighty":25.985328,"marketCap":1015584616},{"date":"2025-04-25","current":23.721319,"twenty":9.848341,"median":18.140309,"eighty":25.985661,"marketCap":1030548976},{"date":"2025-04-28","current":23.583773,"twenty":9.848341,"median":18.140309,"eighty":25.985661,"marketCap":1024573446}],"updateTime":1745998454150}}}